TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ORMP

Oramed Pharmaceuticals Inc

Healthcare · Biotechnology

4.70$ +1.1% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Oramed Pharmaceuticals Inc (ORMP): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/13/2026.

Next report 08/13/2026
Last report 08/10/2026
Earnings surprise by quarter (%)
Q3 23 · 11.1 % 23 Q4 23 · 375.0 % 23 Q1 24 · 100.0 % 24 Q2 24 · 1,200.0 % 24 Q3 24 · -2,300.0 % 24 Q4 24 · -1,376.0 % 24 Q1 25 · -533.3 % 25 Q2 25 · 875.0 % 25 Q3 25 · 2,925.0 % 25 Q4 25 · 412.5 % 25 Q2 26 · -120.9 % 26

EPS estimate beaten

Full history 31 of 50 quarters (62%)
Last 16 quarters 11 of 16 quarters (69%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/17/2026 ORAMED PHARMACEUTICALS INC. (ORMP): Submission of Matters to a Vote of Security Holders · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?